[Gene therapy vector: retroviral vector]

[Article in Japanese]

Affiliations

Review

[Article in Japanese]

S Yamaguchi et al. Tanpakushitsu Kakusan Koso. 1997 Jul.

. 1997 Jul;42(10 Suppl):1789-97.

¹ Department of Molecular Biotherapy Research, Japanese Foundation for Cancer Research, Tokyo, Japan.

No abstract available

Similar articles

Reconstituting retroviral (ReCon) vectors facilitating delivery of cytotoxic genes in cancer gene therapy approaches.
Brandtner EM, Kodajova P, Hlavaty J, Jandl G, Tabotta W, Salmons B, Günzburg WH, Hohenadl C. Brandtner EM, et al. J Gene Med. 2008 Feb;10(2):113-22. doi: 10.1002/jgm.1143. J Gene Med. 2008. PMID: 18076132
Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors.
Ramsey WJ, Caplen NJ, Li Q, Higginbotham JN, Shah M, Blaese RM. Ramsey WJ, et al. Biochem Biophys Res Commun. 1998 May 29;246(3):912-9. doi: 10.1006/bbrc.1998.8726. Biochem Biophys Res Commun. 1998. PMID: 9618311
A heterologous system for assembly of retroviral gene vectors: intracellular budding in yeast?
Tolmachov O. Tolmachov O. Med Hypotheses. 2006;67(4):807-9. doi: 10.1016/j.mehy.2006.04.017. Epub 2006 Jun 8. Med Hypotheses. 2006. PMID: 16759811
Recent advances in retrovirus vector-mediated gene therapy: teaching an old vector new tricks.
Weber E, Anderson WF, Kasahara N. Weber E, et al. Curr Opin Mol Ther. 2001 Oct;3(5):439-53. Curr Opin Mol Ther. 2001. PMID: 11699888 Review.
Retroviral vector production in the National Gene Vector Laboratory at Indiana University.
Cornetta K, Matheson L, Ballas C. Cornetta K, et al. Gene Ther. 2005 Oct;12 Suppl 1:S28-35. doi: 10.1038/sj.gt.3302613. Gene Ther. 2005. PMID: 16231053 Review.